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Abstract Hemicryptophanes have recently emerged as an attractive
class of cages due to their interesting applications as supramolecular re-
ceptors and catalysts. Over the last decade, substantial advances have
been made regarding the preparation of enantiopure versions of these
synthetic receptors. Enantiopure hemicryptophanes are commonly ob-
tained through the separation of diastereomers by chromatography, or
by resolution of racemic mixtures using chiral HPLC. This short review
summarizes the existing methods to access to these chiral organic ar-
chitectures and discusses the benefits and drawbacks of each approach.
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1 Introduction
Chirality plays a crucial role in numerous biochemical
processes of living systems, such as enzymatic catalysis and
the recognition of neurotransmitters and carbohydrates by
natural receptors. Based on the ‘lock and key’ model pro-
posed by E. Fischer, artificial receptors have been developed
to mimic these stereoselective molecular associations and
recognition phenomena.1 Enantiopure molecular contain-
ers, presenting a well-defined cavity suitable for the stereo-
selective complexation of chiral guests, have found numer-
ous applications ranging from fundamental to applied
fields of chemical sciences.2 Two main strategies have been
followed to build enantiopure molecular receptors, involv-
ing either covalent or self-assembled approaches. On one
hand, enantiopure self-assembling systems, like coordina-
tion cages, can be obtained after a few synthetic steps, and
provide a chiral inner space designed for the binding of ap-
propriate guests.3–9 On the other hand, enantiopure cova-
lent receptors, the synthesis of which is often more tedious
than their self-assembled counterparts, have emerged as an
important class of artificial receptors. It is in this last cate-
gory that calixarenes,10 cavitands,11 resorcinarenes,12 fol-
damers,13 cryptophanes,14 cyclodextrins,15 molecular bas-
kets,16 etc. have shown impressive results toward chiral rec-
ognition and enantioselective catalysis. The chirality of
these receptors is either due to the introduction of a chiral
unit in their structures (for example, a stereogenic center or
a sub-unit presenting axial chirality), or to the inherent chi-
rality of the host arising from the bowl shape of its molecu-
lar scaffold.11a,17 This review is designed to establish a ‘state-
of-the-art’ of the existing strategies that can be followed to
synthesize, purify, and characterize a specific class of enan-
tiopure covalent cages named hemicryptophanes. Studies
related to any other class of chiral covalent hosts are beyond
the scope of this review, which is aimed at triggering the
reader’s interest in the emerging hemicryptophane archi-
tectures.
Compared to cryptophanes,14 which combine two cyclo-
triveratrylene (CTV) units, hemicryptophanes associate a
CTV moiety with another C3 symmetrical unit. Their het-
eroditopic character has allowed for their use as receptors,
supramolecular catalysts, and molecular switches.18 The
CTV moiety, which constitutes the northern part of these
cages, is an inherently chiral unit with a M or P configura-
tion,19 whereas their southern part commonly aims at in-
troducing inner functionalities (Figure 1). It should be not-
ed that when an enantiomer (M or P) of a CTV unit is not
closed at its lower part (open-shell structure), it can racem-
ize. Indeed, these atropoisomers typically display energy
barriers for racemization in the range of 112 kJ mol–1 at 293
K, corresponding to half-life times of several months at this
temperature.18,19 The absolute configuration of the CTV unit
is usually assigned by comparison of the experimental elec-
tronic circular dichroism (ECD) spectrum with the calculat-
ed ECD spectrum of a benchmark CTV, as previously report-
ed by Collet and co-workers19b for other CTV derivatives. In-
deed, the ECD spectra of CTV-based compounds present an
exciton pattern roughly centered on the isotropic absorp-
tion of the 1LA (240 nm) transition with the sign being poor-
ly sensitive to the nature of the substituents, allowing for
the convenient assignment of the absolute configuration of
the CTV moiety.19b The first synthesis of a (racemic) hemi-
cryptophane cage was reported in 1982 by Collet and
Lehn.18a However, it was not until 2005 that the first syn-
thesis of an enantiopure hemicryptophane was described
by Crassous and Dutasta (Figure 1).20 The reported strategy
involved the introduction of stereogenic centers in order to
form diastereomers which can be separated by chromatog-
raphy. Another approach, based on the resolution of race-
mic mixtures of either key CTV intermediates or final mo-
lecular cages, has also been recently developed. The latter
approach turns out to be promising as it can easily provide
the desired enantiopure cages on gram scale. The first part
of this review will be devoted toward the synthesis of enan-
tiopure hemicryptophanes by association of racemic CTV
units with chiral enantiopure moieties and the subsequent
separation of the resulting diastereomeric cages. The sec-
ond part deals with the use of chiral HPLC to resolve race-
mic mixtures of CTV or cages, allowing for an easier access
to enantiopure hemicryptophane receptors.
2 Enantiopure Hemicryptophanes Obtained 
by Introducing Additional Chiral Units and 
Separation of Diastereomers
Enantiopure hemicryptophanes can be obtained by dif-
ferent strategies. Among them, introducing chiral centers
with controlled stereochemistry on the hemicryptophane
structure allows for the formation of diastereomers and
avoids the resolution of enantiomers. However, most of the
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Figure 1  Structures of (a) the first hemicryptophane synthesized in 
1982 by Collet and Lehn (racemic mixture), and (b) the first enantio-
pure hemicryptophane reported by Crassous and Dutasta in 2005
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time, this strategy involves more complicated synthetic
pathways.
Hemicryptophanes with additional chiral groups graft-
ed onto the chiral CTV unit can be obtained following two
methods:
(i) By intramolecular macrocyclization reactions (com-
monly called the ‘template approach’) where the synthesis
starts from the south of the molecule by the introduction of
the platform, the linkers (bearing stereogenic units), and fi-
nally the veratryl moieties (at the northern side); a final in-
tramolecular Friedel–Crafts alkylation generates the chiral
CTV unit and closes the hemicryptophane (Figure 2a).
(ii) By coupling a racemic mixture of a preformed CTV
with another C3 symmetrical unit appended with three chi-
ral enantiopure linkers (Figure 2b).
This section will be divided into two parts. The first part
deals with the synthesis of enantiopure hemicryptophanes
possessing stereogenic centers or sub-units presenting axi-
al chirality, through intramolecular macrocyclization reac-
tions. The second part will describe the synthesis of enan-
tiopure hemicryptophanes starting from preformed CTV
units.
2.1 Synthesis by Means of Intramolecular Macro-
cyclization Reactions
In 2005, Crassous and Dutasta originally reported the
first synthesis of an enantiopure hemicryptophane bearing
stereogenic centers by introducing a chiral trialkanolamine
moiety at the southern part of the cage.20 These compounds
are of great interest due to their potential use as ligands for
the endohedral coordination of metal cations in an enantio-
merically pure environment. The enantiopure cage com-
pounds 8 and 9 were obtained by applying an eight-step
synthetic strategy starting from the reaction of vanillyl al-
cohol with dibromoethane in EtOH, which afforded com-
pound 1 (Scheme 1).
Alcohol 1 is then protected with THP to give 2 with an
overall yield of 27%. Allyloxyphenol is then O-alkylated by
compound 2 in the presence of a base (Cs2CO3) in DMF to
give 3 in 75% yield. Deprotection of 3 into the phenol deriv-
ative 4, followed by its reactions with enantiopure R-glyc-
idyl nosylate provided the epoxide 5 in an excellent overall
yield of 87%. The subsequent nucleophilic substitution of 5
with ammonia leads to the primary amine 6. Compound 7
is then obtained by reaction of 6 with 2 equivalents of the
epoxide 5, followed by an acetylation reaction. The latter
synthetic step aims at decreasing the overall polarity of the
cage precursor, leading to an easier purification of 7 by col-
Figure 2  Synthetic strategies for the construction of hemicryptophanes bearing chiral groups: (a) by formation of the CTV unit; (b) by [1+1] coupling 
of the north and south parts
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umn chromatography. Formation of the capsule (R,R,R)-8
was achieved through the cyclization of the intermediate 7
in CH3CN catalyzed by the Lewis acid scandium triflate
[Sc(OTf)3] to yield to the diastereomers P-(R,R,R)-8 and M-
(R,R,R)-8, which could be separated by column chromatog-
raphy. Finally, the targeted enantiopure cages P-(R,R,R)-9
and M-(R,R,R)-9 were obtained by deprotection of the hy-
droxy groups using methanolic NaOH. Furthermore, it
should be noted that the other diastereomeric pairs P-
(S,S,S)-8/M-(S,S,S)-8 and P-(S,S,S)-9/M-(S,S,S)-9 were suc-
cessfully synthesized by applying an identical synthetic
pathway utilizing the (S) enantiomer of glycidyl nosylate.
Interestingly, it was demonstrated that the enantiopure re-
ceptors 9 displayed remarkable diastereo- and enantiose-
lectivity for the binding of carbohydrate substrates. Howev-
er, relatively low binding constants were reported (around
102 M–1).21
In 2014, Martinez and co-workers also exploited the
‘template approach’ to build enantiopure hemicrypto-
phanes bearing triamide and tris(2-aminoethyl)amine
(TREN) features at their southern part (Scheme 2). Such
structures were designed for the enantioselective recogni-
tion of cationic species like ephedrine and norephedrine.22
The southern part of the triamide-based host 12 was firstly
built from the reaction between nitrilotriacetic acid and
three equivalents of enantiopure (S)-4-methoxybenzyl-
amine in the presence of P(OPh)3, yielding the tripodal tri-
amidoamine 10 (Scheme 2). Deprotection of the methoxy
group (yielding 11) was followed by reaction with com-
Scheme 1  Synthesis of hemicryptophanes M-(R,R,R)-9 and P-(R,R,R)-9 bearing trialkanol moieties
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pound 2 (see Scheme 1) in DMF using Cs2CO3 as the base to
give the desired cyclization precursor 12-p. The diastereo-
meric mixture of hemicryptophane P-(R,R,R)-12 and M-
(R,R,R)-12 was obtained through the formation of its north-
ern CTV by an acid-catalyzed triple macrocyclization in for-
mic acid, which occurred in 35% yield. Both the P-(R,R,R)-12
and M-(R,R,R)-12 diastereomers were efficiently separated
by preparative achiral TLC. Finally, a diastereomeric mix-
ture of the TREN-based hemicryptophanes P-(R,R,R)-13 and
M-(R,R,R)-13 was obtained upon reduction of the amide
functions of 12 using borane dimethyl sulfide (BMS) in THF.
Interestingly, in this case, the authors reported an easier
separation of the P-(R,R,R)-13 and M-(R,R,R)-13 diastereo-
mers by simple column chromatography on silica gel. The
introduction of triamide and TREN units at the southern
part of 12 and 13 was found to positively influence the af-
finities of these receptors toward the binding of carbohy-
drates. Indeed, the reported binding constants for 12 and 13
were up to ten times stronger than those of the previously
described hemicryptophanes 9 (ca. 103 and 102 M–1, respec-
tively). Despite the good diastereoselectivities observed for
these supramolecular hosts [for instance, P-(R,R,R)-13 pref-
erentially binds OctGlc with respect to OctGal with an
important 1:31 diastereoselectivity), they failed at provid-
ing significant enantioselectivities.
In 2016, Dutasta and Martinez further extended their
synthetic strategy to the synthesis of more sophisticated
hemicryptophanes 18, simultaneously displaying three
types of chiral elements: (i) a helically chiral CTV, (ii) three
axially chiral binaphthol linkages, and (iii) three stereogenic
carbons on the trialkanol moiety.23 The eight different ste-
reoisomers of the cage 18 were obtained following a five-
step synthetic pathway (Scheme 3). Compound (S)-14 was
firstly obtained through the nucleophilic substitution of
(S)-BINOL with 2 (see Scheme 1) in the presence of the
K2CO3 as the base in acetone. Its subsequent reaction with
(S)-glycidyl nosylate in DMF provided the epoxide (S,S)-15,
which was then reacted with an excess of ammonia in
methanol leading to the formation of the primary amine
(S,S)-16. Two equivalents of compound (S,S)-15 were then
Scheme 2  Synthesis of enantiopure hemicryptophanes 12 and 13 incorporating TREN moieties
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Scheme 3  Synthesis of enantiopure hemicryptophanes 18, incorporating binaphthyl moieties, through intramolecular macrocyclization reactions
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Scheme 4  Synthesis of enantiopure hemicryptophanes 20 based on a benzenic platform
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connected with (S,S)-16 to afford the precursor (S,S,S)-
(S,S,S)-17 in an overall yield of 28%. Finally, the two diaste-
reoisomers P-(S,S,S)-(S,S,S)-18 and M-(S,S,S)-(S,S,S)-18 were
obtained in moderate yields through the treatment of
(S,S,S)-(S,S,S)-17 with Sc(OTf)3 in CH3CN leading to CTV for-
mation by intramolecular cyclization. The other three ste-
reoisomer pairs [P-(R,R,R)-(R,R,R)-18/M-(R,R,R)-(R,R,R)-18,
P-(S,S,S)-(R,R,R)-18/M-(S,S,S)-(R,R,R)-18 and P-(R,R,R)-
(S,S,S)-18/M-(R,R,R)-(S,S,S)-18] were obtained by using the
appropriate enantiopure BINOL and glycidyl nosylate start-
ing materials. ECD analysis of the different stereoisomers of
18 revealed overlapped signals for the CTV and binaphthyl
groups, precluding the assignment of their absolute config-
uration by the method described by Collet et al.19b However,
the authors overcame this issue by developing a chemical
correlation method. Each enantiopure molecule was syn-
thesized through the [1+1] coupling of enantiopure north
and south parts (see Section 3.2, Scheme 14). Absolute con-
figurations were then determined by comparison with
these authentic cages. Once engaged in the recognition of
carbohydrates (glucose and mannose derivatives), these
new enantiopure cages revealed interesting stereoselective
recognition events. It was indeed shown that only the M-
(S,S,S)-(R,R,R) and the P-(R,R,R)-(S,S,S) stereoisomers of 18
were able to bind glucose derivatives, attesting to remark-
able diastereoselective interactions.22 Good enantioselec-
tivity towards the anomer OctGlc was also observed with
binding constants six times higher for P-(R,R,R)-(S,S,S)-18
than for M-(S,S,S)-(R,R,R)-18 (association constants of 537
M–1 and 83 M–1 respectively in CDCl3).
The same authors further explored a similar synthetic
pathway, based on the derivatization of the intermediate
14, in order to build new hemicryptophane structures
based on a tripodal benzenic platform (Scheme 4).24 The
chiral BINOL linkers found in the capsules 20 allowed for
the convenient separation of the P-(R,R,R)-20 and P-(R,R,R)-
20 isomers by simple column chromatography.24
The precursor 19 was obtained through the nucleophilic
substitution of 14 with tris(bromomethyl)benzene in DMF
using Cs2CO3 as the base. The cyclization step was per-
formed in CH3CN with Sc(OTf)3 as the catalyst, giving one
pair of diastereomers, P-(R,R,R)-20 and M-(R,R,R)-20, with a
moderate diastereoselectivity (1:1.3 ratio). Recognition to-
ward carbohydrates was investigated showing that binding
constants of up to 458 M–1 were possible and that exclusive
enantioselectivity and diastereoselectivity could be
reached.
Enantiopure hemicryptophanes based on bio-relevant
macrocyclic chiral platforms have also attracted attention
due to their potential applications as bio-inspired recep-
tors. Such cages are indeed merging the CTV recognition
properties with those of the macrocyclic unit.
Hutton and co-workers reported an enantiopure hemic-
ryptophane containing a cyclic peptide.25 This system was
built from the alkylation of the cyclic peptide 21 with bro-
moethyl vanillyl alcohol 2 which yielded the precursor 22
(Scheme 5). The northern CTV was then generated by treat-
ment of the precursor with formic acid leading to the race-
mate of cage 23 with an overall yield of 35%. The two dias-
tereomers, formed in a 2:1 mixture, were successfully puri-
fied by column chromatography. The cyclic peptide 21,
made of six residues (tyrosine and glycine alternatively),
was previously prepared by cyclization (ByBOP, 1 h, quanti-
tative yield) of the corresponding linear peptide, which was
synthesized on a solid support (2-chlorotrityl resin) and
cleaved with 5% TFA. Recognition towards the biologically
relevant zwitterion carnitine was investigated and the
hemicryptophanes 23 showed modest chiral discrimination
behavior: using P-23 as the receptor, a binding constant 1.5
times higher for R-carnitine than for S-carnitine was found
(Ka of 4.1·103 and 2.7·103 M–1 respectively in acetonitrile).
An interesting example of chiral macrocycle-based
hemicryptophanes was also reported by Chambron et al.26
This system connects one northern CTV to a tripodal per-
Scheme 5  Synthesis of enantiopure hemicryptophanes incorporating 
a cyclic peptide
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methylated -cyclodextrin feature, aiming at providing a
pair of diastereomers. The hemicryptophane precursor 25p
was easily obtained in one synthetic step (49% yield) by the
alkylation of the starting cyclodextrin with compound 24 in
the presence of an excess of sodium hydride in DMF
(Scheme 6). However, the final hemicryptophane closure
reaction, through intramolecular cyclization, affords a dia-
stereomeric mixture of cages 25 in very low yields. Indeed,
formic acid and Sc(OTf)3-promoted cyclizations resulted in
8% and 5% yield, respectively. The M and P diastereomers
were formed in a 6:1 ratio and the authors were able to iso-
late the major diastereomer in pure form.
2.2 [1+1] Coupling of the CTV and the Southern 
Part
The [1+1] coupling reaction between a CTV racemate
and another chiral enantiomerically pure tripodal unit has
been also investigated as an alternative strategy to con-
struct optically pure hemicryptophanes.
In 2015, Martinez, Dutasta and co-workers proposed
that the thermodynamic resolution of a CTV racemic mix-
ture by coupling with an enantiopure southern unit might
represent a straightforward access to enantiopure hemi-
cryptophanes, avoiding tedious separation of diastereo-
mers.27 The authors demonstrated the feasibility of the ap-
proach through the construction of three capsules follow-
ing a [1+1] approach. Three reductive amination reactions
between the aldehyde-based CTV 26 and three enantiopure
TREN derivatives, (S,S,S)-TREN-R3, were conducted (Scheme
7). In all cases, the exclusive formation of the M-(S,S,S) dia-
stereomers of hemicryptophanes 27 (15–22% yield) were
Scheme 6  Synthesis of hemicryptophanes incorporating a cyclodextrin platform
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observed, independently of the nature of the TREN substit-
uents. This behavior was explained by two different kinds
of reaction between the TREN unit and the two enantio-
mers of CTV 26. It was observed that reaction with M-26
led to the formation of well-defined and soluble cages M-
(S,S,S)-27, while the reaction with P-26 gave only insoluble
polymeric species.
In 2013, Chambron et al. further extended their work on
macrocycle-based hemicryptophanes by connecting a CTV
unit with a tripodal cyclodextrin through a triple disulfide-
bridge feature (Scheme 8).28
The racemic mixture of the triply bridged hemicrypto-
phane 31 was obtained in 11% yield through the intermo-
lecular formation of disulfide bonds between the cyclodex-
trin 29 and the racemate of CTV 30, which both display
three thiol substituents. Synthesis of the desired trisubsti-
tuted -cyclodextrin 29 was achieved through the metha-
nolysis of the three thioester substituents of the cyclodex-
trin 28 in the presence of K2CO3. The final coupling step be-
tween 29 and 30 was performed by the addition of a
solution of I2 in MeOH to a methanolic solution of the two
partners, yielding the M and P diastereomers of 31 as a 5:3
mixture. It was therefore demonstrated that the thermo-
dynamic equilibrium, which controls the disulfide bridge
formation, favors the formation of the M diastereoisomer
over the P diastereoisomer. However, despite this promising
selectivity, the two diastereomers were not successfully
separated.
3 Enantiopure Hemicryptophanes Obtained 
by Means of Chiral HPLC Resolution of Enan-
tiomers
The use of the chiral semi-preparative high-perfor-
mance liquid chromatography (HPLC) technique for the res-
olution of racemic mixtures is part of the few approaches
that can be followed to synthesize highly enantiopure
hemicryptophanes. Following this HPLC-based strategy, en-
antiopure covalent cages can be obtained by (i) resolution
of the final hemicryptophane racemate, or (ii) building of
the cage from a resolved mixture of CTV-based precursors.
In this section we will provide examples of versatile opti-
cally pure hemicryptophane structures, which can be ob-
tained following the HPLC purification method, as well as a
brief description of their putative applications in supramo-
lecular recognition and catalysis.
3.1 Resolution of Hemicryptophane Racemates
In 2010, Martinez, Dutasta and co-workers reported the
first example of the resolution of a racemic mixture of
hemicryptophane molecular cages using the chiral semi-
preparative HPLC purification technique.29 They demon-
strated the feasibility of (i) the isolation of both P- and M-
enantiomers of hemicryptophane 32 through successive in-
jections (8.0 mg/mL solutions in CDCl3) of the racemic mix-
ture on a (S,S) Whelk-O1 chiral column, and (ii) the assign-
ment of their absolute configuration. The study of the
circular dichroism (CD) of the first [(+)-32] and second eluted
[(–)-32] enantiomers allowed the authors to assign (+)-32
to the P-stereomer and (–)-32 to the M-stereomer. Excellent
enantiomeric excesses of >99% and >96% for the first eluted
P- and the second eluted M-enantiomer were observed. It
should be noted that the racemic mixture of 32 was ob-
tained following an identical pathway to that described in
Scheme 2, but using methylbenzylamine instead of (S/R)-4-
methoxy--benzylamine. The ability of the (+)- and (–)-ste-
reoisomers of 32 to act as hosts for carbohydrate derivatives
was further studied by 1H NMR titration experiments. Spe-
cific recognitions of - and -anomers of D-glucose deriva-
Scheme 8  Coupling of a CTV unit and a cyclodextrin containing sulfide 
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tives were interestingly observed.21 However, this good en-
antioselectivity was associated with relatively weak associ-
ation constants (typically below 102 M–1). Furthermore, it
should be noted that (i) the resolved hemicryptophane en-
antiomers were only obtained on milligram scale, and (ii)
the chiral HPLC technique was found to be highly sensitive
to structural modifications of the capsules. This purifica-
tion technique indeed failed at purifying a racemic mixture
of the previously reported hemicryptophane 3330 bearing a
TREN moiety in its southern part (Scheme 9, a). Therefore,
only small changes in the structure of a hemicryptophane
can strongly impact the effectiveness of its optical resolu-
tion. However, chiral HPLC was reported as an effective tool
for the resolution of one derivative of 33 incorporating an
azaphosphatrane moiety in its southern part: PH+@33
(Scheme 9, b).31
Scheme 9  (a) Synthesis of hemicryptophane 33 starting from 32. (b) 
Preparation of the encaged azaphosphatrane PH+@33
Since these initial reports, substantial progress has been
made by the group of Martinez regarding resolution of
hemicryptophane racemic mixtures. They exploited the
chiral HPLC tool to obtain the enantiopure cages (M)-34,
(P)-34, (M)-35 and (P)-35, containing a tris(2-pyridylmeth-
yl)amine (TPA) moiety at their southern parts, on a prepar-
ative scale of close to hundreds of milligrams (Scheme
10).32 The hemicryptophane racemates 34 and 35, respec-
tively bearing naphthyl- and phenyl linkers, have both been
obtained in a fourteen-step synthesis on gram scale. These
two supramolecular cages were able to coordinate a Zn(II)
metal cation at their southern TPA unit (Scheme 10). Both
cages were prepared starting from the TPA-trichloride pre-
cursor TPACl3, which was obtained in a seven-step synthetic
procedure (Scheme 11) with an overall yield of 45%. The
precursors 34-p and 35-p were prepared from the conden-
sation between TPACl3 and the naphthyl and phenyl inter-
mediates 34-i and 35-i, respectively (Scheme 10). Closure of
the hemicryptophane 35 was achieved through the final
building of its northern CTV unit following a triple macro-
cyclization reaction in formic acid (Scheme 10, b). The au-
thors explained the remarkable effectiveness of this cage-
closing reaction (90% yield, isolated by precipitation) by the
putative protonation of the TPA unit leading to a pre-orga-
nized cyclization precursor. In the case of 34, the triple
macrocyclization closing reaction was performed in the
presence of the Lewis acid Sc(OTf)3 in CH3CN, rather than in
formic acid, due to the formation of several undesired prod-
ucts in the latter case.
Remarkably, the racemic mixtures of both hemicrypto-
phanes 34 and 35 were successfully resolved by chiral
HPLC, representing the first example of enantiopure TPA-
based molecular capsules. The M- and P-stereoisomers of
34 and 35 were effectively separated on a Chiralpak ID col-
umn on preparative scales of 80 mg and 50 mg of each en-
antiomer with ee values >99% in, respectively, 12 and 3
hours. The absolute configurations of each enantiopure
hemicryptophane (+)-34, (–)-34, (+)-35 and (–)-35 were
determined by comparison of their ECD spectra with previ-
ously characterized optically pure CTV-based struc-
tures.22,25,29,33 The authors finally demonstrated the ability
of the heteroditopic Zn(II) hemicryptophane complex Zn-
35 (Scheme 10) to act as a supramolecular receptor for
zwitterionic guests. Despite these promising synthetic and
binding results, to date, studies of these optically pure TPA-
based hosts for stereo- and enantioselective encapsulations
have not been reported.
In connection with their previous studies on the stereo-
selective recognition of carbohydrates,21,22 in 2018, Marti-
nez, Dutasta and co-workers reported new advances to-
wards selective guest recognition dictated by the inner heli-
cal chirality of the CTV unit. These researchers designed the
first optically pure (M- and P-) hemicryptophane hosts si-
multaneously displaying enantioselectivities in recognition
and strong binding constants towards carbohydrate
guests.34 The racemic mixture of the cage 37 was obtained
in four steps starting from the previously reported
CTV(CH2CH2Br)3 precursor.35 CTV(CH2CH2Br)3 was firstly
derivatized into the CTV(CH2CH2NH2)3 intermediate
(Scheme 12); 37 was then obtained in a 42% yield through a
[1+1] coupling cage-closing reductive amination with the C3
derivative 36.
The (–)-M and (+)-P stereoisomers of 37 were efficiently
discriminated by chiral HPLC. Separation on a semi-prepar-
ative Chiralpak ID column [EtOH and Et3N/CH2Cl2 (50:50)
eluent] led to the isolation of both enantiomers with ee val-
ues >98.5%. It was demonstrated through recognition stud-
OMe
MeO O
O
O
O
O
O
N
HN
HN
NH
OMe
MeO O
O
O
O
O
O
N
N
N
N
P
O
O
O
BH3·SiMe2
THF
30%
OMe
MeO O
O
O
O
O
O
N
N
N
N
P
[(CH3)2N]2PCl
CH3CN
40 °C
35%
a) tBuOK, THF
b) toluene
       35%
OMe OMe
OMe
MeO O
O
O
O
O
O
N
HN
HN
NH
OMeOMe
H+
(±)-32
Chiral HPLC optical resolution
(±)-33
Chiral HPLC optical resolution
PH+@(±)-33
Chiral HPLC optical resolution
(±)-33
P@(±)-33
a)
b)
ies of six carbohydrate stereoisomers that the P- and M-ste-
reoisomers of the host 37 display remarkable enantioselec-
tivities [exclusive for galactose derivatives which are only
recognized by M-37 (Figure 3)], together with relatively
high binding constants (Ka > 103 M–1 in some cases). This
switch in substrate recognition properties, depending on
the enantiomer of the host, represents a new strategy for
the fine-tuning of hemicryptophane hosts in order to selec-
tively recognize the targeted sugar derivative.
Scheme 10  Synthesis of the racemic mixtures of hemicryptophanes 34 and 35
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Scheme 11  Synthesis of the precursor TPACl3
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Figure 3  DFT-optimized structure of Oct-B-Glc@M-37
3.2 Resolution of CTV-Based Precursor Racemates
As reported in the previous section, optical resolution of
the racemic mixture of a desired hemicryptophane, by
means of semi-preparative chiral HPLC, is a highly valuable
qualitative method to obtain optically pure organic archi-
tectures. However, this strategy suffers from two major
drawbacks: (i) the efficiency of the chiral HPLC separation
which is highly sensitive to the structure of the desired cap-
sules, and (ii) the amounts of isolated products which are
sometimes low (milligram scale) even when the synthesis
of the racemic mixture is performed on gram scale.32 There-
fore, the development of new and easily accessible strate-
gies for the preparation and purification of versatile enan-
tiopure hemicryptophanes, on a relatively large scale, is of
particular importance. For a variety of applications ranging
from sensing, delivering and transportation to synthesis
and catalysis in confined spaces, being able to rapidly build
versatile nanocages on gram scale is indeed critical. With
such consideration in mind, Martinez, Vanthuyne and co-
workers have been working on a novel approach based on
the optical resolution of one CTV-based key intermediate
on a relatively large scale prior to building the desired
hemicryptophane cages.36 Following this strategy, new op-
tically pure hemicryptophanes could be obtained in three
steps starting from the racemic mixture of the key interme-
diate by: (1) optical resolution, (2) synthetic derivatization,
and (3) a cage-closing reaction (Scheme 13). To be regarded
as reliable, such an approach, based on the derivatization of
an enantiopure CTV intermediate, must respect some basic
requirements: (i) a rapid and straightforward preparation
of each enantiomer of the key precursor on gram scale, (ii)
the synthetic derivatizations and cage-closing reactions
must be accessible under mild conditions to avoid racem-
ization of the CTV unit, and (iii) the preservation of the en-
antiopurity must be easily checked during all steps of the
synthetic process. The quest for such key intermediates led
to success in 2016 with the preparation of 2 grams of each
of the M- and P-enantiomers of the precursor
CTV(CH2CH2Br)3 (Scheme 13), with an enantiomeric excess
>99.5% by means of preparative chiral HPLC. A study of the
energy barrier for the interconversion process of
CTV(CH2CH2Br)3 was performed revealing a negligible de-
pendence on the solvent polarity, and a much stronger tem-
perature dependence. Half-life times for each enantiomer of
CTV(CH2CH2Br)3 is 5 months at 25 °C and 7 days at 40 °C.
The authors therefore claim that steps 2 [derivatization of
CTV(CH2CH2Br)3] and 3 (cage-closure reactions) must be
performed at room temperature regardless of the nature of
the solvent.
This important breakthrough was followed by the gram-
scale preparation of eight optically pure hemicryptophanes,
which were obtained in four steps in reaction times of one
week (Figure 4).36 In order to decrease the typical reaction
temperature for the first derivatization step (nucleophilic
substitution between OH and Br, see Scheme 13, step c), the
optimized reaction conditions described the use of Cs2CO3
as the base in DMF at 298 K for 48 hours. Under these con-
ditions, the M- and P-stereoisomers of the CTV aldehyde
precursors (Scheme 13) were easily isolated in 92% to 98%
yield. The optically pure hemicryptophanes were subse-
quently obtained by introducing a southern C3 TREN unit
via a [1+1] reductive amination cage-closing reaction with
the CTV aldehyde precursors, under standard conditions
(Scheme 13, step d). Finally, the retention of the absolute
configuration of all eight isolated hemicryptophanes, com-
pared to their respective enantiopure CTV precursors, was
clearly confirmed by measurement of ee values in an ele-
gant 1H NMR study involving D-camphorsulfonic acid as a
chiral resolving agent. Importantly, the authors obtained
1.4 grams of the optically pure cage compound M-33 in
only a one-week period (four steps), highlighting the partic-
Scheme 12  Synthesis of hemicryptophane 37 (racemic)
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ular effectiveness of the approach. Furthermore, it should
be noted that the chiral HPLC resolution of the racemic
mixture of the same cage 33 was found to be unsuccessful
(see Scheme 9).
Once the concept had been proven, the same group fur-
ther exemplified the versatility of the approach. Aiming at
increasing the level of complexity found in hemicrypto-
phane structures, the cage 18, possessing three types of ste-
reogenic elements, was designed, synthesized, and success-
fully isolated.23
Starting from the M- and P-enantiomers of
CTV(CH2CH2Br)3, binaphthol and trialkanol chiral units
were respectively introduced as linkers and southern moi-
eties of the new architecture. The enantiopure versions of
18 were obtained in 25% yield by a simple [1+1] macrocy-
clization reaction between resolved CTV(CH2CH2Br)3 and
enantiopure triphenol (S,S,S)-(S,S,S)-41 (Scheme 14). The
resulting cage displays helical, axial and central chirality
through its CTV hat (northern part), its three binaphthol
walls (linkers) and its trialkanol C3 unit (southern part). The
(S)-binaphthol unit derivatized with a (S,S,S)-trialkanol unit
(S,S,S)-(S,S,S)-41 was previously synthesized in five steps
(Scheme 15).
Both (P)-(S,S,S)-(S,S,S)-18 and (M)-(S,S,S)-(S,S,S)-18 were
obtained starting from the P- or M-CTV(CH2CH2Br)3 iso-
mers. P- and M-(R,R,R)-(R,R,R)-18 were prepared starting
from (R,R,R)-(R,R,R)-41; and finally (P)-(S,S,S)-(R,R,R)-18
was achieved using the (R)-(–)-glycidyl nosylate precursor
to prepare the (S,S,S)-(R,R,R)-41 intermediate. The enantio-
Scheme 14  (a) Synthesis of the hemicryptophane P-(S,S,S)-(S,S,S)-18 via a [1+1] closing reaction. (b) Structure of the hemicryptophane P-(R,R,R)-
(R,R,R)-18 displaying three kinds of chirality
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pure version of hemicryptophane 18 has been recently
used as a metal ligand, aiming at introducing a metal-based
active center in a controlled chiral environment. The oxido-
vanadium complexes based on the P-(S,S,S)-(S,S,S)-, M-
(S,S,S)-(S,S,S)-, P-(S,S,S)-(R,R,R)- and M-(S,S,S)-(R,R,R)- ste-
reoisomers of the cage 18 were obtained in one step by re-
acting one equivalent of vanadium oxytriisopropoxide with
the desired ligand through the coordination of the trial-
kanolamine moieties (Scheme 16).37
Once engaged in the oxidation of sulfide substrates,
these optically pure catalysts displayed strong improve-
ment of the catalytic activities (compared to their parent
model devoid of the cavity), as well as remarkable substrate
selectivity behavior (Scheme 16, a).37 Despite their promis-
ing first and second chiral coordination spheres, no asym-
metric oxidation was detected with all four stereoisomers
of 18. However, it should be noted that replacing the north-
ern CTV moiety by a simple phenyl substituent, as in 42
(Scheme 16, b), led to the formation of a bowl-shaped oxi-
dovanadium catalyst capable of catalyzing the direct asym-
metric oxidation of thioanisole with 19% ee in an 83%
yield.38
The scope of the synthetic strategy based on resolved
M- and P-stereoisomers of CTV(CH2CH2Br)3 was also ex-
tended to the synthesis of the novel optically pure M- and
P-(S,S,S)-43 open structures (Scheme 17).39
The latter were used as references to unambiguously
determine the absolute configuration of four novel open
CTV hosts: M- and P-(S,S,S)-43 and M- and P-(R,R,R)-43.
These architectures were designed to compare the ability of
Scheme 16  (a) Structure of the oxidovanadium active center confined inside the hydrophobic cavity of 18, together with the representation of the 
substrate selectivity (illustrated by the inhibition of the thioanisole oxidation observed when the Me4N+ competitive guest is bound inside the cavity). 
(b) Synthesis of the oxidovanadium complex (O=VV)-42
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Scheme 17  Synthesis of (S,S,S)-(S,S,S)-43
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open- and close-shell CTV-BINOL-based enantiopure recep-
tors (Figure 5) to efficiently recognize and bind biologically
relevant substrates (carbohydrates).24 Interestingly, im-
proved enantio- and diastereoselectivities were observed
for the closed hemicryptophanes 20 (see Section 2.1) com-
pared to their open counterparts, highlighting the crucial
role of the cage-like organic architecture.
Finally, an interesting example of optically pure hemi-
cryptophanes, prepared from an optically resolved CTV
precursor, was described back in 2010 by Diederich, Thilgen
and co-workers.40 The chiral functionalization of an achiral
C60 fullerene by an enantiomerically pure CTV-malonate 44
was achieved by means of a triple Bingle addition yielding
the targeted chiral hemicryptophane structures 45 and 46
(Scheme 18). The CTV-malonate intermediate 44 arises
from the derivatization of an optically pure CTV(triol)3 pre-
cursor that had been previously resolved by chiral HPLC.
The authors reported the formation of the four CTV-C60
conjugates, (–)-45a, (+)-45b, (+)-46a, and (–)-46b, which
were isolated and fully characterized by means of 1H NMR,
13C NMR, HRMS-MALDI-TOF, UV/Vis, ECD (Electronic Circu-
lar Dichroism) and VCD (Vibrational Circular Dichroism)
analysis.
Figure 5  (a) Structures of the four stereoisomers of 43. (b) The corresponding closed-shell hemicryptophanes 20
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The exclusive formation of four isomers among the
eight theoretically expected (23) indicated the exclusive for-
mation of the trans-3, trans-3, trans-3 tris adducts, and at-
tests to the complete regioselectivity of the Bingle addition
without racemization of the P- or M-stereoisomers of 44.
However, it should be noted that the amounts of the P- and
M-isomers of the CTV(triol)3 precursors that could be iso-
lated by chiral HPLC were low, with only 32 mg of each en-
antiomer obtained after several injections. Therefore, only
small quantities (ranging from 3.4 to 5.0 mg) of the four
CTV-C60 adducts (–)-45a, (+)-45b, (+)-46a, and (–)-46b
were obtained, illustrating the difficulty in obtaining large
amounts of enantiomerically pure hemicryptophanes.
4 Conclusion
In summary, this short review highlights the recent
work related to optically pure hemicryptophane architec-
tures and provides an overall view of the synthetic ap-
proaches available for their preparation and purification.
Two main strategies have been classically applied in or-
der to obtain enantiopure hemicryptophanes. The first ap-
proach, consisting of the introduction of stereogenic cen-
ters to generate diastereomers, was originally considered in
order to avoid chiral separation of enantiomers. Following
this strategy, covalent structures connecting a CTV unit
with enantiopure trialkanolamine, TREN, BINOL, trialkanol,
cyclic peptide and -cyclodextrin derivatives have been ob-
tained by following a ‘template approach’ (hemicrypto-
phane closure by intramolecular cyclization) or a [1+1] in-
termolecular coupling strategy. However, this approach suf-
fers from complicated synthetic pathways, which often
limits its versatility.
While initially considered a challenging task, the chiral
separation of hemicryptophane enantiomers has lately be-
come an attractive alternative due to the considerable prog-
ress achieved in the field of chiral HPLC purification tech-
niques. Indeed, numerous separations of enantiopure
hemicryptophanes, displaying versatile structures, have
been recently achieved on relatively comfortable scales
(hundreds of milligrams), highlighting the powerful and
practical nature of chiral HLPC-based optical resolution.
Importantly, the optical resolution of a key CTV intermedi-
ate, prior to building the desired hemicryptophane cage,
was demonstrated to be a particularly efficient alternative
approach. Following this second approach, elaborated
hemicryptophanes could be conveniently obtained on gram
scale over a reaction period of one week.
Altogether, these two different approaches allow for an
easier and more straightforward access to enantiopure
hemicryptophanes. We therefore believe that this review
might (i) attract the attention of synthetic chemists toward
the construction of chiral supramolecular architectures,
and (ii) allow for an easier choice between the existing
solutions to obtain enantiopure capsules.
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